{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:40Z","timestamp":1767134920481,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd008253.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T00:00:00Z","timestamp":1434931200000}}],"reference-count":23,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008253.pub4","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T16:38:58Z","timestamp":1434991138000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis"],"prefix":"10.1002","volume":"2015","author":[{"given":"Helen","family":"Beer","sequence":"first","affiliation":[{"name":"Alder Hey Children's NHS Foundation Trust; ENT Department; Eaton Road Liverpool UK L12 2AP"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W","family":"Southern","sequence":"additional","affiliation":[{"name":"University of Liverpool; Department of Women's and Children's Health; Alder Hey Children's NHS Foundation Trust Eaton Road Liverpool Merseyside UK L12 2AP"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C","family":"Swift","sequence":"additional","affiliation":[{"name":"University Hospital, Aintree; Department of Otolaryngology; Aintree Liverpool UK L9 7AL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD008253.pub4-BIB0001|cit1","first-page":"63","article-title":"A prospective treatment trial of nasal polyps in adults with cystic fibrosis","volume":"38","author":"Hadfield","year":"2000","journal-title":"Rhinology"},{"issue":"6","key":"10.1002\/14651858.CD008253.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","article-title":"Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening","volume":"19","author":"Bobadilla","year":"2002","journal-title":"Human mutation"},{"key":"10.1002\/14651858.CD008253.pub4-BIB0003|cit3","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"September 2009"},{"issue":"4","key":"10.1002\/14651858.CD008253.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1183\/09031936.04.00014404","article-title":"Intranasal steroids decrease eosinophils but not mucous expression in nasal polyps","volume":"24","author":"Burgel","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD008253.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD008253.pub4-BIB0006|cit6","first-page":"97","article-title":"EPOS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists","volume":"45","author":"Fokkens","year":"2007","journal-title":"Rhinology"},{"key":"10.1002\/14651858.CD008253.pub4-BIB0007|cit7","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2007","volume":"20","author":"Fokkens","year":"2007","journal-title":"Rhinology. Supplement"},{"issue":"11","key":"10.1002\/14651858.CD008253.pub4-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1136\/thorax.55.11.946","article-title":"Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis","volume":"55","author":"Gee","year":"2000","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD008253.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/28.4.717","article-title":"Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study","volume":"28","author":"Hedman","year":"1999","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD008253.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1378\/chest.121.1.40","article-title":"Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis","volume":"121","author":"Henriksson","year":"2002","journal-title":"Chest"},{"issue":"7414","key":"10.1002\/14651858.CD008253.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008253.pub4-BIB0012|cit12","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"5","key":"10.1002\/14651858.CD008253.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal Outcome Test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clinical Otolaryngology"},{"issue":"2","key":"10.1002\/14651858.CD008253.pub4-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006549","article-title":"Topical steroids for nasal polyps","author":"Kim","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD008253.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archotol.124.5.513","article-title":"Effect of fluticasone in severe polyposis","volume":"124","author":"Lund","year":"1998","journal-title":"Archives of Otolaryngology - Head and Neck Surgery"},{"key":"10.1002\/14651858.CD008253.pub4-BIB0016|cit16","first-page":"137","article-title":"Imaging and staging","volume-title":"In Nasal Polyposis: An Inflammatory Disease and Its Treatment","author":"Mackay","year":"1997"},{"issue":"1","key":"10.1002\/14651858.CD008253.pub4-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005232.pub2","article-title":"Oral steroids for nasal polyps","author":"Patiar","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008253.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"key":"10.1002\/14651858.CD008253.pub4-BIB0019|cit19","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"3","key":"10.1002\/14651858.CD008253.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.prrv.2008.04.003","article-title":"Nasal and sinus disease in cystic fibrosis","volume":"9","author":"Robertson","year":"2008","journal-title":"Paediatric Respiratory Review"},{"issue":"9","key":"10.1002\/14651858.CD008253.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.ijporl.2008.05.011","article-title":"Sinus surgery in cystic fibrosis patients: comparison of sinus and lower airway cultures","volume":"72","author":"Roby","year":"2008","journal-title":"International Journal of Pediatric Otorhinolaryngology"},{"issue":"3","key":"10.1002\/14651858.CD008253.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000102068","article-title":"Cystic fibrosis and formes frustes of CFTR-related disease","volume":"74","author":"Southern","year":"2007","journal-title":"Respiration"},{"issue":"5","key":"10.1002\/14651858.CD008253.pub4-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008253.pub2","article-title":"Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis","author":"Beer","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008253.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:14:16Z","timestamp":1720678456000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008253.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008253.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}